Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Gaithersburg, Maryland
- Most recent report
- 8-K, filed Nov 4, 2026
- Incorporated
- Delaware
- Filings on record
- 1,001+ filings
- On EDGAR
- CIK 1367644
- Fiscal year ends
- December
- Filer status
- Accelerated filer
Financials 8 of 51
News 8 of 202
Prospectuses and Registrations 8 of 19
- S-8 Registration statement for an employee plan Apr 30, 2026
- S-3 Shelf registration statement Aug 7, 2025
- 424B3 Prospectus supplement for an offering Mar 24, 2025
- POS AM Post-effective amendment to a registration Mar 4, 2025
- 424B3 Prospectus supplement for an offering Mar 4, 2025
- 424B3 Prospectus supplement for an offering Dec 4, 2024
- S-1/A Registration statement for an offering, amended Dec 2, 2024
- S-1 Registration statement for an offering Nov 12, 2024
Proxies 8 of 29
- DEFA14A Extra proxy material Apr 28, 2026
- DEFA14A Extra proxy material Apr 27, 2026
- DEFA14A Extra proxy material Apr 22, 2026
- DEFA14A Extra proxy material Apr 16, 2026
- DEFA14A Extra proxy material Apr 16, 2026
- DEFA14A Extra proxy material Mar 20, 2026
- DEF 14A Proxy statement for a shareholder vote Mar 20, 2026
- DEF 14A Proxy statement for a shareholder vote Mar 21, 2025
Ownership 8 of 630
- 144 Notice of a proposed sale of restricted stock Oct 7, 2026
- 4 Insider reported a trade Oct 7, 2026
- 4 Insider reported a trade Oct 5, 2026
- 144 Notice of a proposed sale of restricted stock Oct 1, 2026
- SCHEDULE 13G Large holder reported a passive stake Aug 14, 2026
- 3 Insider reported their initial holding Aug 12, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Jul 31, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Jul 28, 2026
Other 8 of 70
- ARS Annual report sent to shareholders Mar 20, 2026
- EFFECT Notice that a registration became effective Aug 15, 2025
- CORRESP Reply to SEC staff Aug 13, 2025
- UPLOAD Comment letter from SEC staff Aug 13, 2025
- EFFECT Notice that a registration became effective Mar 24, 2025
- ARS Annual report sent to shareholders Mar 21, 2025
- POS EX Mar 4, 2025
- EFFECT Notice that a registration became effective Dec 4, 2024
Everything here comes from Emergent BioSolutions Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.